Papillary microcarcinomas of the thyroid gland and immunohistochemical analysis of expression of p53 protein in papillary microcarcinomas

Journal of Translational Medicine

Volumn 4, Issue , 2006, Pages

  Corapcioglu, Demet ^a   Sak, Serpil D ^a   Delibasi, Tuncay ^a   Tonyukuk, Vedia ^a   Kamel, Nuri ^a   Uysal, Ali R ^a   Kocak, Savas ^a   Aydintug, Semih ^a   Erdogan, Gurbuz ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; PROTEIN P53; THYROXINE;

ADULT; AGE; AGED; ARTICLE; ASPIRATION BIOPSY; CANCER HORMONE THERAPY; CANCER INVASION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; FOLLOW UP; FROZEN SECTION; GENDER; HASHIMOTO DISEASE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; NECK METASTASIS; PROGNOSIS; PROTEIN EXPRESSION; SOFT TISSUE METASTASIS; STATISTICAL SIGNIFICANCE; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 33747026761     PISSN: 14795876     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-4-28     Document Type: Article

References (65)

1. Allo MD, Christianson W, Koivunen D: Not all "occult" papillary carcinomas are "minimal". Surgery 1988, 104:971-6.
2. Boehm T, Rothouse L, Wartofsky L: Metastatic occult follicular thyroid carcinoma. JAMA 1976, 235:2420-1.
3. Bondeson L, Ljungberg O: Occult thyroid carcinoma at autopsy in Malmö, Sweden. Cancer 1981, 47:319-23.
4. Bondeson L, Ljungberg O: Occult papillary thyroid carcinoma in young and aged. Cancer 1984, 53:1790-2.
5. Franssila KO, Harach R: Occult papillary carcinoma of the thyroid in children and young adults. Cancer 1986, 58:715-19.
6. Hedinger C: In WHO International Histological Classification of Tumors. 2nd edition. Berlin: Springer 1988:9-11.
7. Kasai N, Sakomoto A: New subgroupig of small thyroid carcinomas. Cancer 1987, 60:1767-70.
8. Burguera B, Gharib H: Thyroid incidentalomas: Prevalence, diagnosis, significance, and management. Endocrinol Metab Clin North Am 2000, 29:187-203.
9. Koischwitz D: Ultrasound of the neck. Radiol Clin North Am 2000, 38:1029-45.
10. Hubert JP, Kiernan PD, Beahrs OH: Occult papillary carcinoma of thyroid. Arch Surg 1980, 115:394-98.
11. Farooki MA: Epidemiology and pathology of cancer of the thyroid. I. Material, methods and results. Int Surg 1969, 51:232-43.
12. Harach RH, Franssila KO, Wasenius V: Occult papillary carcinoma of the thyroid. A "normal" finding in Finland. A systematic autposy study. Cancer 1985, 56:531-8.
13. Delides GS, Elemenoglou J, Lekkas CH, Kittas CH, Evthimiou C: Occult thyroid carcinoma in a Greek population. Neoplasma 1987, 34:119-25.
14. Yamamoto Y, Maeda T, Izumi K, Otsuka H: Occult papillary carcinoma of the thyroid. A study of 408 autopsy cases. Cancer 1990, 65:1173-9.
15. Pelizzo MR, Piotto A, Rubello D, Casara D, Fassina A, Busnardo B: High prevelence of occult papillary thyroid carcinoma in a surgical series for benign thyroid disease. Tumori 1990, 76:255-7.
16. Furmancuk AW, Roussak N, Ruchti C: Occult thyroid carcinomas in the region of Minsk, Belarus. An autopsy study of 215 patients. Histopathology 1993, 23:319-25.
17. Komorowski RA, Hanson GA: Occult thyroid pathology in the young adult. An autopsy study of 138 patients without clinical thyroid disease. Hum Pathol 1988, 19:689-96.
18. Lang W, Borrusch H, Bauer L: Occult carcinomas of the thyroid. Evaluation of 1020 sequential autopsies. Am J Clin Pathol 1988, 90:72-6.
19. Sugino K, Ito K, Ozaki O, et al.: Papillay microcarcinoma of the thyroid. J Endocrinol Invest 1998, 21:445-8.
20. Baudin E: Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute experience. Cancer 1998, 83:553-9.
21. Moosa M, Mazzaferri EL: Occult thyroid carcinoma. Cancer 1997, 9:87-90.
22. Ain KB: Papillary thyroid carcinoma etiology, assessment and therapy. Endocrinol Metab Clin North Am 1995, 24:711-15.
23. Noguchi S, Yamashita H, Murakami N, Nakayama I, Toda M, Kawamoto H: Small carcinomas of the thyroid - a long term follow up of 867 patients. Arch Surg 1996, 31:87-91.
24. Hay ID, Grant CS, Van Heerden JA, Goellner JR, Ebersold JR, Bergstralh EJ: Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50 year period. Surgery 1992, 112:1139-47.
25. Selivanova G, Wiman KG: P53: a cell cyle regulator activated by DNA damage. Adv Cancer Res 1995, 66:143-80.
26. Levine AJ, Momand J, Finlay CA: The p53 tumor suppressor gene. Nature 1991, 351:453-6.
27. Martinez J, Georgof I, Levine AJ: Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Genes Dev 1991, 5:151-9.
28. Finlay CA, Hinds PW, Levine AJ: The p53 proto-oncogene can act as a suppressor of transformation. Cell 1989, 57:1083-93.
29. Dobashi Y, Sakamoto A, Sugimura H, et al.: Overexpression of p53 as a possible prognostic factor in human thyroid carcinoma. Am J Surg Pathol 1993, 17:375-81.
30. Donghi R, Longoni A, Pilotti S, Michieli P, Della-Porta G, Pierotti MA: Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland. J Clin Invest 1993, 91:1753-60.
31. Godballe C, Asschenfelt P, Jorgensen KE, et al.: Prognostic factors in papillary and follicular thyroid carcinomas: p53 expression is a significant indicator of prognosis. Laryngoscope 1998, 108:243-9.
32. Nishida T, Nakao K, Hamaji M, Nakahara MA, Tsumimoto M: Overexpression of p53 protein and DNA content are important biologic prognostic factors for thyroid cancer. Surgery 1996, 119:568-75.
33. Fritsche M, Haessler C, Brandner G: Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene 1993, 8:307-18.
34. Salvadori B, Del Bo R, Pilotti S, Grassi M, Cusumano F. "Occult" Papillary Carcinoma of the Thyroid: a Questionable Entity. Eur J Cancer 1993, 29A:1817-20.
35. Sampson RJ, Key CR, Buncher CP, Lijima S: Smallest forms of papillary carcinoma of the thyroid: A study of 141 microcarcinomas less than 0.1 cm in greatest dimention. Arch Pathol 1971, 91:334-9.
36. Lin JD, Huang BY, Chao TC, Hsueh C: Diagnosis of Occult Thyroid Carcinoma by Thyroid Ultrasonography with Fine Needle Aspiration Cytology. Acta Cytologica 1997, 41:1751-56.
37. Fialkow PJ: The Origin and Development of Human Tumors Studies with Cell Markers. N Eng J Med 1974, 291:26-33.
38. Hazard JB: Small papillary carcinoma of the thyroid: A study with special reference to so-called nonencapsulated sclerosing tumor. Lab Invest 1960, 9:86-97.
39. Hirabayashi RN, Lindsay S: The relationship of Thyroid carcinoma and chronic Thyroiditis. Surg Gynecol Obstet 1965, 121:243-52.
40. Shalini G, Aneeta P, Angela F, et al.: Infiltration of differentiated thyroid carcinoma by proliferating lymphocytes is associated with improved disease-free survival for children and young adults. J Clin Endocrinol Metab 2001, 86:1346-54.
41. Woolner LB, Lemmon ML, Beahrs OH, Black BM, Keating FR: Occult papillary carcinoma of the thyroid gland: A study of 140 cases observed in a 30 year period. J Clin Endocrinol 1960, 20:89-105.
42. Yamashita H, Noguchi S, Murakami N, et al.: Extracapsular invasion of lymph node metastasis. Cancer 1999, 86:842-9.
43. Schoder DM, Chambors A, France CJ: Operative strategy for thyroid cancer: Is total thyroidectomy worth the price. Cancer 1986, 58:2320-8.
44. Vickery AL, Wang C, Walker AM: Treatment of intrathyroidal papillary carcinoma of the thyroid. Cancer 1987, 60:2587-95.
45. Rossi R, Cady b, Silverman ML, Wool MS, Horner TA: Current results of conservative surgery for differentieted thyroid carcinoma. World J Surg 1986, 10:612-22.
46. Strate M, Lee EL, Chiders JH: Occult papillary carcinoma of the thyroid with distant metastases. Cancer 1984, 54:1093-100.
47. Harach HR, Franssila KO: Occult Papillary Carcinoma of the Thyroid Appearing as Lung Metastasis. Arch Path Lab Med 1984, 108:529-30.
48. Laskin WB, James LP: Occult papillary carcinoma of the thyroid with pulmonary metastases. Hum Pathol 1983, 14:83-5.
49. Fend f, Gruber U, Fritzsche H, Rothmund J, Breitfellner G, Mikuz G: Occult papillary carcinoma of the thyroid with pulmonary lymphengitic spread diagnosed by lung biopsy. Klin Wochenschr 1989, 67:687-90.
50. Paksoy N, Ozturk H, Demircan A, Artvinli M: Occult papillary carcinoma of the thyroid presenting as an intratracheal tumour. Eur J Surg Oncol 1994, 20:694-5.
51. Michie HR, O'Bryan-Tear CG, Marsh H, Glazer G: Cerebral metastases from occult papillary carcinoma of the thyroid. Br J Surg 1987, 74:647.
52. Lloyd RV, Bieierwaltes WH: Occult sclerosing carcinoma of the thyroid. South Med J 1983, 76:437-9.
53. Jancic-Zguricas M, Jankovic R: Occult papillary carcinoma of the thyroid gland revealed by cancer pericarditis. Pathol Res Pract 1986, 181:761-6.
54. Matias-Guiu X, Cuatrecasas M, Musulen E, Prat J: p53 expression in anaplastic carcinomas arising from thyroid papillary carcinomas. J Clin Pathol 1994, 47:337-9.
55. Kikuchi S, Hiraide H, Tamakuma S, Yamamoto M: Expression of wild-type p53 tumor suppressor gene and its possible involvement in the apoptosis of thyroid tumors. Surg Today 1997, 27:226-33.
56. Chen BK, Ohtsuki Y, Furihata M, Takeuchi T, Iwata J, Liang SB, Sonobe H: Co-overexpression of p53 protein and epidermal growth factor receptor in human papillary thyroid carcinoma correlated with lymph node metastasis, tumor size and clinicopathologic stage. Int J Oncol 1999, 15:893-8.
57. Williams ED: Mechanisms and pathogenesis of thyroidcancer in animals and man. Mutat Res 1995, 333:123-9.
58. Vecchio G, Santoro M: Oncogenes and thyroid cancer. Clin Chem Lab Med 2000, 38:113-6.
59. Gillenwater AM, Weber RS: Thyroid carcinoma. Cancer Treat Res 1997, 90:149-69.
60. Fagin JA: Tumor suppressor genes in huan thyroid neoplasms: p53 mutations are associated undifferentiated thyroid cancers. J Endocrinol Invest 1995, 18:140-2.
61. Karlsson MG, Hardell L, Haliquist A: No association between immunuhistýchemical expression of p53, c-erbB-2, Ki-67, estrogen and progesterone receptors in female papillary thyroid cancer and ionizing radiation. Cancer Lett 1997, 120:173-7.
62. Pellegriti G, Scollo C, Lumera G, Regalbuto C, Vigneri R, Belflore A: Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases. J Clin Endocrinol Metab 2004, 89:3713-20.
63. Michie HP, O'Bryan-Tear CG, Marsh H, Glazer G: Cerebral metastases from occult papillary carcinoma of the thyroid. Br J Surg 1987, 74:647.
64. 131) therapy. Thyroid 2000, 10:975-9.
65. Ruter A, Dreifus J, Jones M, Nishiyama R, Lennquist S: Overexpression of p53 in tall cell variants of papillary thyroid carcinoma. Surgery 1996, 120:1046-50.